Apellis Pharmaceuticals to Present at the Bank of America Securities 2022 Healthcare Conference

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation at the Bank of America Securities 2022 Healthcare Conference on May 11, 2022, at 8:40 a.m. PT. The event will feature a live webcast accessible through the company’s website, and a replay will be available for 30 days afterward.

As a leader in complement therapies, Apellis focuses on developing transformative treatments for diseases related to complement cascade activation across various fields, including hematology, ophthalmology, nephrology, and neurology.

WALTHAM, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will present at the Bank of America Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 8:40 a.m. PT .

The event will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 30 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com. 

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com 
617.599.8178

FAQ

When is Apellis Pharmaceuticals presenting at the Bank of America Healthcare Conference?

Apellis Pharmaceuticals will present at the Bank of America Securities 2022 Healthcare Conference on May 11, 2022, at 8:40 a.m. PT.

How can I watch the Apellis Pharmaceuticals presentation live?

The presentation will be available via a live webcast on the 'Events and Presentations' page of the Investors and Media section of Apellis Pharmaceuticals' website.

Will there be a replay of the Apellis Pharmaceuticals conference presentation?

Yes, a replay of the webcast will be available for 30 days following the event.

What is the focus of Apellis Pharmaceuticals in the biopharmaceutical industry?

Apellis Pharmaceuticals focuses on developing therapies that target the complement system to treat debilitating diseases in areas such as hematology, ophthalmology, nephrology, and neurology.